Perhaps TEVA thinks it has better use for the money or perhaps they think the shares will get cheaper. I'm very disappointed in the way this stock has acted. I believe generics are a good place to be in but Mylan appears to be running on all cylinders while TEVA is in reverse.
I'm very disappointed in the way this stock has acted.
Dumsani, I do not think there is a person on this board who is not disappointed with the way this stock has behaved. The company remains strong, is growing and has a great looking future. We have had many of the regular members of this board give up this year and move on, I certainly cannot blame them. I choose to stick at this point because I am very thick headed and believe things will eventually turn. I also have plenty of cash to invest at the moment. I believe we have more downside in the market coming and I am being very patient. Levin has been on the job now for about 6 months and he appears to be moving things in the right direction, it does however take time. During his short stint we have seen a bunch of positives, notwithstanding the fact that Teva supposedly has a plethora of drugs in late stage development. I am waiting for next month to hear what the man has to say and will make my decision then.